A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Kathiravan, M. K.
- Herbal Medicine:Back to the Future (Volume 2) (Vascular Health)
Authors
1 Department of Pharmacognosy and Phytochemistry, Parul Institute of Pharmacy & Research, Parul University, Waghodia - 391760, Gujarat, IN
2 Department of Pharmaceutics, Ikon Pharmacy College, Bheemanahalli - 562109, Karnataka, IN
3 Department of Pharmaceutical Chemistry, Dr APJ Kalam Research Laboratory, College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur - 603203, Tamil Nadu, IN
Source
Journal of Natural Remedies, Vol 20, No 1 (2020), Pagination: 68-69Abstract
No Abstract.Keywords
CVD, Hypertension, Hyperlipidemia, Obesity.- In silico Screening of Chemical Constituents in Rasam as a Beneficial Supplementary Treatment for Novel Coronavirus
Authors
1 Department of Pharmacognosy and Phytochemistry, Parul Institute of Pharmacy and Research, Parul University, Vadodara, Gujarat – 391760, IN
2 Department of Pharmaceutical Chemistry, J.S.S. College of Pharmacy, Udhagamandalam, Tamil Nadu – 643001, IN
3 Dr. APJ Abdul Kalam Research Laboratory, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu – 603203, IN
Source
Journal of Natural Remedies, Vol 21, No 4 (2021), Pagination: 357-365Abstract
Context: The novel coronavirus named as COVID-19 (SARS-CoV-2) from its origin in Hubei spread across the continent in a short period of six months’ time. Till date there is no drug to cure the novel corona virus SARS-CoV-2. Earlier studies on SARS-CoV-1 suggests that interleukin 6 (IL-6) and Interleukin 8 (IL-8) were in the higher levels indicating the key role of IL. Aim: Molecular simulation studies were carried out on the selected 24 chemical constituents present in rasam against IL-6 to identify the key interaction between the amino acid residues and their chemical structure. Materials and Methods: A library of 24 chemical constituents was sketched using Chem Sketch programming 8.0. The 3D structures of ligands were retrieved in mol format in Maestro v 11.3 and the ligands were optimized utilizing ligprep (4.3) module (Schrödinger 2018-1). Results: One of the chemical constituents sinigrin a glucosinolate emerged as top scorer with a GLIDE score of -6.333. It was apparent from the examination, that the Van der Waals (ΔG bindvdW) and coulomb energy interactions were major great contributors. The structural diversity of sinigrin from the rest of other chemical constituents in rasam led to significantly better interaction with amino acid residues. Conclusion: The study identifies sinigrin, as one of the active constituents in rasam possessing good binding affinity against IL-6 which can be used as a dietary supplement and can be used as a control measure to fight against Covid-19.Keywords
Functional Food, IL-6 Inhibitor, SARS-CoV-2, Sinigrin, Tartaric Acid.References
- Kathiravan MK, Radhakrishnan S, Namasivayam V, Palaniappan S. An overview of spike surface glycoprotein in severe acute respiratory syndromecorona virus. Front Mol Biosci. 2021. https://doi.org/10.3389/fmolb.2021.637550. PMid:33898518. PMCid:PMC8058706
- Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014; 6(10). https://doi.org/10.1101/cshperspect.a016295. PMid:25190079 PMCid:PMC4176007
- Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015; 16(5):448–57. https://doi.org/10.1038/ni.3153. PMid:25898198
- Jones SA, Scheller J, Rose-John S. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest. 2011; 121(9):3375–83. https://doi.org/10.1172/JCI57158.PMid:21881215 PMCid:PMC3163962
- Kontzias A, Kotlyar A, Laurence A, Changelian P, O'Shea JJ. Jakinibs: A new class of kinase inhibitors in cancer and autoimmune disease. Curr Opin Pharmacol. 2012; 12(4):464–70. https://doi.org/10.1016/j.coph.2012.06.008. PMid:22819198. PMCid:PMC3419278
- Magro G. SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides Tocilizumab? SGP130Fc. Cytokine X. 2020; 2(2):100029. https://doi.org/10.1016/j.cytox.2020.100029. PMid:32421092. PMCid:PMC7224649
- Wang WK, Chen SY, Liu IJ, Kao CL, Chen HL, Chiang BL, et al. severe acute respiratory syndrome research group of the National Taiwan University College of Medicine/NTU Hospital. Temporal relationship of viral load, ribavirin, interleukin (IL)- 6, IL-8, and clinical progression in patients with severe acute respiratory syndrome. Clin Infect Dis. 2004; 39(7):1071–5. https://doi.org/10.1086/423808. PMid:15472864.PMCid:PMC7107918
- Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. Detectable serum severe acute respiratory syndrome corona virus 2 Viral Load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in Critically Ill patients with corona virus disease 2019. Clin Infect Dis 2020; 71(8):1937-42. https://doi.org/10.1093/cid/ciaa449. PMid:32301997. PMCid:PMC7184354
- Chen W, Lan Y, Yuan X, Deng X, Li Y, Cai X, et al. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect. 2020; 9(1):469–73. https://doi.org/10.1080/22221751.2020.1732837. PMid:32102625. PMCid:PMC7054964
- Devarajan A, Mohanmarugaraja MK. A comprehensive review on rasam: A South Indian traditional functional food. Pharmacogn Rev. 2017; 11(22):73–82. https://doi.org/10.4103/phrev.phrev_13_17. PMid: 28989243. PMCid:PMC5628526
- Bolla K, Santhi KV, Afnan KS, Krishnaveni P, Kusuma M. Effect of diet counseling on type 2 diabetes mellitus. Int J Sci Technol Res. 2015; 4:112–8.
- Rani VE, Paulraj S. Impact of dietary intervention with a functional food supplement to combat anemia– The blood iron metabolic disorder among the coffee plantation labourers. Funct Food Health Dis. 2013;3:21–36. https://doi.org/10.31989/ffhd. v3i1.66
- Rajan S, Baburaj DS, Sethuraman M, Parimala S. Stem and stem bark used medicinally by the tribals Irulas and Paniyas of Nilgiri district, Tamil Nadu. J Nat Rem. 2001;1:49–54.
- Rao PD, Babu MS, Rao VL. Persistent traditional practices among the tribals of north coastal Andhra Pradesh. Stud Tribes Tribals. 2006; 4:53–6. https://doi.org/10.1080/0972639X.2006.11886537
- Nithya TG, Dahineeswari V, Chowdhury SR, Sivakumar S. Antibacterial activity of Thaaleesaadhi chooranam against human pathogens. Int J Drug Discov Herb Res. 2011; 1:224–30.
- Swapna B. An ethnobotanical survey of plants used by Yanadi tribe of Kavali, Nellore district, Andhra Pradesh, India. J Sci Innov Res. 2015;4:22–6.
- Nayak AK, Shalini. Chickenpox customs, beliefs and traditional practices in Udupi district: A case study. Nitte Univ J Health Sci. 2013;3:102–4. https://doi.
- org/10.1055/s-0040-1703664
- Devarajan A, Mohanmarugaraja MK. A comprehensive review on rasam: A South Indian traditional functional food. Pharmacognosy Reviews. 2017; 11(22):73–82. https://doi.org/10.4103/phrev.phrev_13_17. PMid:28989243. PMCid:PMC5628526
- Devarajan A, Mohanmarugaraja MK. Standardization and chemical analysis of rasam: A South Indian traditional functional food. Pharmacognosy Journal. 2017;9(5):587–93. https://doi.org/10.5530/ pj.2017.5.93
- Devarajan A, Mohanmarugaraja MK. Anti-microbial studies on rasam: A south Indian traditional functional food. World J Pharm Res. 2017; 6(5):766– 74. https://doi.org/10.20959/wjpr20175-8330
- Devarajan A, Mohanmarugaraja MK. Anti-platelet aggregation study on rasam: A south Indian traditional functional food. Indo Am J Pharm Res. 2017; 7(4):8134–9.
- Devarajan A, Mohanmarugaraja MK. Marker based analytical studies on rasam: A south Indian traditional functional food. World J Pharm Res. 2017; 6(8):2054–65. https://doi.org/10.20959/wjpr20178- 9181
- Devarajan A, Mohanmarugaraja MK. Identification and analysis of chemical constituents of rasam by gas chromatography-mass spectrometry (GC-MS). Res J Pharm Technol. 2017; 10(12):4183–7. https://doi.org/10.5958/0974-360X.2017.00763.6
- Devarajan A, Mohanmarugaraja MK. Cytotoxic, antimitotic, and antiproliferation studies on rasam: A south Indian traditional functional food. Pharmacogn Mag. 2017; 13(Suppl 3):S452–7. https://doi.org/10. 4103/pm.pm_138_17. PMid:29142398.PMCid:PMC 5669081
- Mohanmarugaraja MK, Devarajan A, Kathiravan MK. Rasam (south Indian Spice Soup) - attenuates the mammary tumor induction magnitude of 7,12-dimethylbenz[a] anthracene in sprague-dawley rats. Pharmacogn Mag. 2020; 16, Suppl S2:467–73. https://doi.org/10.4103/pm.pm_150_20
- Sharma A, Mohanmarugaraja MK, Manne R. Evaluation of physicochemical properties and chemical constituents of rasam, a traditional south Indian Soup. J Pharm Res Int. 2021; 33(17):18–25. https://doi.org/10.9734/jpri/2021/v33i1731302
- Maurya VK, Kumar S, Prasad AK, Bhatt MLB, Saxena SK. Structure-based drug designing for potential antiviral activity of selected natural products from ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. Virus disease. 2020; 31(2):179–93. https://doi.org/10.1007/s13337-020- 00598-8. PMid:32656311.PMCid:PMC7245990
- Pandey P, Rane JS, Chatterjee A, Kumar A, Khan R, Prakash A, et al. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: An in-silico study for drug development. J Biomol Struct Dyn. 2020; 22:1–11. https://doi.org/10.1080/07391102.2020.1796811. PMid:32698689.PMCid:PMC7441770
- Babu A, Indiraleka M, Mohanmarugaraja MK, Premnath D. Common medicinal plants and their role against COVID-19 for protection and treatment. J Nat Remedies. 2021; 21(2):99–107. https://doi.org/10.18311/jnr/2021/26653
- Srimathi R, Mohanmarugaraja MK, Kathiravan MK. In silico screening of traditional herbal medicine derived chemical constituents for possible potential inhibition against SARS-CoV-2. J Nat Remedies. 2020; 20(2):79–88. https://doi.org/10.18311/jnr/2020/25278
- Kiran G, Karthik L, Devi MSS, Sathiyarajeswaran P, Kanakavalli K, Kumar KM, Ramesh Kumar D. In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein. J Ayurveda Integr Med. 2020. https://doi.org/10.1016/j.jaim.2020.05.009. PM id:32527713. PMCid:PMC7247487
- Sinha SK, Shakya A, Prasad SK, Singh S, Gurav NS, Prasad RS, et al. An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. J Biomol Struct Dyn. 2020.p. 1–12. https://doi.org/10.1080/07391102.2020.1762741. PMCid:PMC7232888
- Prasanth DSNBK, Murahari M, Chandramohan V, Panda SP, Atmakuri LR, Guntupalli C. In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2. J Biomol Struct Dyn. 2020.p. 1–15. https://doi.org/10.1080/07391102.2020.1779129. PMid:32567989.PMCid:PMC7332870
- Ayush.gov.in [homepage on the Internet]. New Delhi: Ministry of AYUSH, Government of India; c2020-21 [cited 2021 April 26]. Available from: https://www.ayush.gov.in/docs/siddha-guidelines.pdf.
- Reddy MBR, Krishnasamy SK, Kathiravan MK. Identification of novel scaffold using ligand and structure-based approach targeting shikimate kinase. Bioorg Chem. 2020; 102pp. https://doi.org/10.1016/j.bioorg.2020.104083. PMid:32745735
- Priya D, Kathiravan MK. Molecular insights into benzene sulphonamide substituted diarylpyrazoles as cyclooxygenase-2 inhibitor and its structural modifications. J Biomol Struct Dyn. 2020. p. 1–12. https://doi.org/10.1080/07391102.2020.1785329. PMid:32602808
- Lin CW, Tsai FJ, Tsai CH, Lai CC, Wan L, Ho TY, et al. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica ischolar_main and plant-derived phenolic compounds. Antiviral Res. 2005; 68(1):36–42. https://doi.org/10.1016/j.antiviral.2005.07.002. PMid:16115693.PMCid:PMC7114321
- Antimicrobial Activity of Curcumin and Deuterated Curcumin
Authors
1 Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRMIST, Kattankulathur, Chennai – 603203, Tamil Nadu, IN
2 Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRMIST, Kattankulathur, Chennai – 603203, Tamil Nadu Dr. A. P. J. Abdul Kalam Research Lab, Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRMIST, Kattankulathur, Chennai – 603203, Tamil Nadu, IN
Source
Journal of Natural Remedies, Vol 22, No 3 (2022), Pagination: 424 - 431Abstract
Deuterium (D) and hydrogen (H) are bioisosteres because they are similar in size and shape with alike physiochemical properties and hence expect similar biological activity. The purpose of replacing H with D is to extend the time the active drug species spends in plasma, resulting in increased effectiveness and/or the avoidance of unwanted side effects. Deutetrabenazine was the first deuterated medicinal molecule, recently authorized by the FDA for the treatment of chorea “an involuntary movement disorder” associated with tardive dyskinesia and Huntington’s disease. Curcumin is found to have a long history of use in human disorders such as inflammation, metabolic syndrome, arthritis, anxiety, antimicrobial, hyperlipidemia, etc., Curcumin’s oral bioavailability and water solubility are low, resulting in poor absorption, rapid metabolism, and systemic elimination. To overcome curcumin’s drawbacks, H/D exchange was performed in curcumin, which was then characterized and tested for antibacterial, antifungal, and anti-tubercular activities. The deuterated compound showed equipotent antibacterial activity when compared with the non-deuterated compound and had better anti-fungal, anti-tubercular activity compared to its parent compound.
Keywords
Antibacterial Antifungal Anti-TB Activity, Deuterated Curcumin.References
- Chang Y, Myers T, Wasa M. B (C6F5) 3‐Catalyzed α‐ Deuteration of Bioactive Carbonyl Compounds with D2O. Adv Synth Catal. 2020; 362(2):360–4. https:// doi.org/10.1002/adsc.201901419. PMid:32256276. PMCid:PMC7108789
- Zhong L, Hou C, Zhang L, Zhao J, Li F, Li W. Synthesis of deuterium-enriched sorafenib derivatives and evalu- ation of their biological activities. Mol Divers. 2019; 23(2):341–50. https://doi.org/10.1007/s11030-018-9875-7. PMid:30238393
- Harbeson SL, Tung RD. Deuterium in drug discovery and development. Annu Rep Med Chem. 2011; 46:403–17. https://doi.org/10.1016/B978-0-12-386009-5.00003-5
- Russak EM, Bednarczyk EM. Impact of deuterium sub- stitution on the pharmacokinetics of pharmaceuticals. Ann Pharmacother. 2019; 53(2):211–6. https://doi. org/10.1177/1060028018797110. PMid:30136594
- Xu R, Zhan M, Peng L, Pang X, Yang J, Zhang T, et al. Design, synthesis and biological evaluation of deuterated nintedanib for improving pharmacokinetic properties. J Labelled Comp Radiopharm. 2015; 58(7):308–12. https:// doi.org/10.1002/jlcr.3299. Mid:26011584
- Jiang J, Pang X, Li L, Dai X, Diao X, Chen X, et al. Effect of N-methyl deuteration on metabolism, and pharmacokinet- ics of enzalutamide. Drug Des Devel Ther. 2016; 10:2181. https://doi.org/10.2147/DDDT.S111352. PMid:27462143. PMCid:PMC4939996
- Harbeson SL, Tung RD. Deuterium in drug discovery and development. Annu Rep Med Chem. 2011; 46:403–17. https://doi.org/10.1016/B978-0-12-386009-5.00003-5
- Schneider F, Bradbury M, Baillie TA, Stamler D, Hellriegel E, Cox DS, et al. Pharmacokinetic and metabolic profile of deu- tetrabenazine (TEV‐50717) compared with tetrabenazine in healthy volunteers. Clin Transl Sci. 2020;13(4):707– 17. https://doi.org/10.1111/cts.12754. PMid:32155315. PMCid:PMC7359938
- Timmins GS. Deuterated drugs: where are we now? Expert opinion on therapeutic patents. 2014; 24(10):1067– 75. https://doi.org/10.1517/13543776.2014.943184. PMid:25069517. PMCid:PMC4579527
- Pirali T, Serafini M, Cargnin S, Genazzani AA. Applications of deuterium in medicinal chemistry. J Med Chem. 2019; 62(11):5276–97. https://doi.org/10.1021/acs. jmedchem.8b01808. PMid:30640460
- Valero M, Weck R, Güssregen S, Atzrodt J, Derdau V. Highly selective directed iridium‐catalyzed hydrogen iso- tope exchange reactions of aliphatic amides. Angew Chem Int Ed. 2018; 57(27):8159–63. https://doi.org/10.1002/ anie.201804010. PMid:29693316. PMCid:PMC6033151
- Ray PC, Pawar YD, Singare DT, Deshpande TN, Singh GP. Novel process for preparation of tetrabenazine and deu- tetrabenazine. Org Process Res Dev. 2018; 22(4):520–6. https://doi.org/10.1021/acs.oprd.8b00011
- Kaur S, Gupta M. Deuteration as a tool for optimiza- tion of metabolic stability and toxicity of drugs. Glob J Pharmaceu Sci. 2017; 1. https://doi.org/10.19080/GJPPS.2017.01.555566
- Hu Y, Liang L, Wei WT, Sun X, Zhang XJ, Yan M. A conve-
- nient synthesis of deuterium labeled amines and nitrogen heterocycles with KOt-Bu/DMSO-d6. Tetrahedron. 2015; 71(9):1425–30. https://doi.org/10.1016/j.tet.2015.01.015
- Liu Z, Ren X, Wang P. A practical synthesis of deuterated methylamine and dimethylamine. J Chem Res. 2021; 45(3– 4):265–8. https://doi.org/10.1177/1747519820969636
- Krause-Heuer AM, Yepuri NR, Darwish TA, Holden PJ. Mild conditions for deuteration of primary and secondary aryl- amines for the synthesis of deuterated optoelectronic organic molecules. Molecules. 2014; 19(11):18604–17. https:// doi.org/10.3390/molecules191118604. PMid:25401402. PMCid:PMC6271713
- Gant TG. Using deuterium in drug discovery: Leaving the label in the drug. J Med Chem. 2014; 57(9):3595–611. https://doi.org/10.1021/jm4007998. PMid:24294889
- Zheng QT, Yang ZH, Yu LY, Ren YY, Huang QX, Liu Q, et al. Synthesis and antioxidant activity of curcumin analogs. J Asian Nat Prod Res. 2017; 19(5):489–503. https://doi.org/1 0.1080/10286020.2016.1235562. PMid:27690628
- Tyagi P, Singh M, Kumari H, Kumari A, Mukhopadhyay K. Bactericidal activity of curcumin I is associated with dam- aging of bacterial membrane. PloS one. 2015; 10(3). https:// doi.org/10.1371/journal.pone.0121313. PMid:25811596. PMCid:PMC4374920
- Burapan S, Kim M, Han J. Curcuminoid demethylation as an alternative metabolism by human intestinal microbiota. J Agric Food Chem. 2017; 65(16):3305–10. https://doi. org/10.1021/acs.jafc.7b00943. PMid:28401758
- Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. Curcumin, a component of golden spice: From bedside to bench and back. Biotechnol Adv. 2014; 32(6):1053–64. https://doi. org/10.1016/j.biotechadv.2014.04.004. PMid:24793420
- Nantasenamat C, Simeon S, Hafeez A, Prachayasittikul V, Worachartcheewan A, Songtawee N, et al. Elucidating the structure-activity relationship of curcumin and its biologi- cal activities. Curcumin: Synthesis, Emerging Role in Pain Management and Health Implications, Pouliquen, DL, (edi- tor); 2014. p. 49–86.
- Leong SW, Faudzi SM, Abas F, Aluwi MF, Rullah K, Wai LK, et al. Synthesis and SAR study of diarylpentanoid analogues as new anti-inflammatory agents. Molecules. 2014; 19(10):16058–81. https://doi.org/10.3390/mole- cules191016058. PMid:25302700. PMCid:PMC6271425
- Yao EC, Xue L. Therapeutic effects of curcumin on Alzheimer’s disease. Advances in Alzheimer’s disease. 2014; 3(04):145. https://doi.org/10.4236/aad.2014.34014
- Teiten MH, Dicato M, Diederich M. Hybrid curcumin com- pounds: a new strategy for cancer treatment. Molecules. 2014; 19(12):20839–63. https://doi.org/10.3390/mole- cules191220839. PMid:25514225. PMCid:PMC6271749
- Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Mol Pharm. 2007; 4(6):807–18. https://doi.org/10.1021/ mp700113r. PMid:17999464
- Mohamed SA, El-Shishtawy RM, Al-Bar OA, Al-Najada AR. Chemical modification of curcumin: Solubility and antioxi- dant capacity. Int J Food Prop. 2017; 20(3):718–24. https:// doi.org/10.1080/10942912.2016.1177545
- Pandit RS, Gaikwad SC, Agarkar GA, Gade AK, Rai M. Curcumin nanoparticles: Physico-chemical fabrication and it’s in vitro efficacy against human pathogens. 3 Biotech. 2015; 5(6):991–7. https://doi.org/10.1007/s13205-015- 0302-9. PMid:28324406. PMCid:PMC4624150
- Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B, et al. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol. 2008; 76(11):1590–611. https://doi.org/10.1016/j.bcp.2008.08.008. PMid:18775680
- Mohan AC, Geetha S, Gajalakshmi R, Divya SR, Dhanarajan MS. Determination of molecular property, bioactivity score and binding energy of the phytochemical compounds pres- ent in Cassia auriculata by molinspiration and DFT method. Texila International Journal of Basic Medical Science. 2017; 2(2):1–5. https://doi.org/10.21522/TIJBMS.2016.02.02. Art002
- Alodeani EA, Arshad M, Izhari MA. Antileishmanial activity and computational studies of some hydrazone derivatives possessing quinoline nucleus. In vitro. 2015; 1:3.
- Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017; 7(1):1–3. https://doi.org/10.1038/srep42717. PMid:28256516. PMCid:PMC5335600
- Sicak Y. Design and antiproliferative and antioxidant activi- ties of furan-based thiosemicarbazides and 1, 2, 4-triazoles: their structure-activity relationship and SwissADME pre- dictions. Med Chem Res. 2021 Aug; 30(8):1557–68. https:// doi.org/10.1007/s00044-021-02756-z
- Liu M, Chen X, Chen T, Yin SF. A facile and general acid-cata- lyzed deuteration at methyl groups of N-heteroarylmethanes. Org Biomol Chem. 2017; 15(12):2507–11. https://doi. org/1.1039/C7OB00062F. PMid:28266672
- Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol. 1992; 13(12):700–5. https://doi.org/10.2307/30146486. PMid:1289397
- Lourenco MC, de Souza MV, Pinheiro AC, Ferreira MD, Gonçalves RS, Nogueira TC, Peralta MA. Evaluation of anti-tubercular activity of nicotinic and isoniazid ana- logues. Arkivoc. 2007; 15:181–91. https://doi.org/10.3998/ark.5550190.0008.f18
- Nona DA, Blake MI, Crespi HL, Katz JJ. Effect of deuterium oxide on the culturing of Penicillium janczewskii II. Isolation of fully deuterated griseofulvin. J Pharm Sci. 1968; 57(6):975–9. https://doi.org/10.1002/jps.2600570611. PMid:4299548
- Lourenco MC, de Souza MV, Pinheiro AC, Ferreira MD, Gonçalves RS, Nogueira TC, Peralta MA. Evaluation of anti-tubercular activity of nicotinic and isoniazid ana- logues. Arkivoc. 2007; 15:181–91. https://doi.org/10.3998/ ark.5550190.0008.f18
- Computational Investigation of Plant-based Bioactive Compounds as Inhibitors against Tuberculosis
Authors
1 Dr. APJ Kalam Research Lab, Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur – 603203, Kancheepuram, Tamil Nadu, IN
2 Department of Pharmacognosy and Phytochemistry, Parul Institute of Pharmacy and Research, Parul University, Vadodara – 391760, Gujarat, IN
3 Dr. APJ Kalam Research Lab, Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur – 603203, Kancheepuram, Tamil Nadu Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur – 603203, Kancheepuram, Tamil Nadu, IN
Source
Journal of Natural Remedies, Vol 22, No 3 (2022), Pagination: 457 - 471Abstract
The objective of the work is to identify a natural origin compound that could have an anti-tubercular effect, thereby preventing the infection in humans using computational approach. Our focus was to find a inhibitor for Enoyl- acyl carrier reductase enzyme and hence chemically diverse scaffolds from plants origin were selected. Admet parameters were performed for the compounds, and the top nine compounds among 50 compounds were found to be non-carcinogenic. The pharmacological predicted activity (Pa) of few compounds such as 14-Deoxy-11,12 didehydroandrographolide, Terflavin B, and Liquirtin was found to be more active when compared with that of the standard reference. Further more the synthesis of these active compounds derivatives can be investigated theoretical followed by its synthesis and evaluation by in vitro activity against the InhA could be of interest.
Keywords
InhA, Liquirtin, Mycobacterium tuberculosis, Molecular Docking, Terflavin B.References
- Zaman K. Tuberculosis: A global health problem. J Health Popul Nutr. 2010; 28(2):111–3. https://doi.org/10.3329/ jhpn.v28i2.4879. PMid:20411672. PMCid:PMC2980871
- Chandir S, Hussain H, Salahuddin N, Amir M, Ali F, Lotia I, et al. Extrapulmonary tuberculosis: A retrospective review of 194 cases at a tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc. 2010; 60(2):105–9. PMID: 20209695.
- Sandhu GK. Tuberculosis: Current situation, challenges and overview of its control programs in India. J Glob Infect Dis. 2011; 3(2):143–50. https://doi.org/10.4103/0974- 777X.81691. PMid:21731301. PMCid:PMC3125027
- Chadha VK. Progress towards millennium development goals for TB control in seven Asian countries. Indian J Tuberc. 2009; 56(1):30–43.PMID: 19402270.
- Smith KC, Armitige L, Wanger A. A review of tuberculo- sis: Reflections on the past, present and future of a global epidemic disease. Expert Rev Anti Infect Ther. 2003; 1(3):483–91. https://doi.org/10.1586/14787210.1.3.483. PMid:15482144
- Singh MM. XDR-TB--danger ahead. Indian J Tuberc. 2007; 54(1):1–2. PMID: 17455416.
- Gupta R, Thakur B, Singh P, Singh HB, Sharma VD, Katoch VM, et al. Anti-tuberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuber- culosis isolates. Indian J Med Res. 2010; 131:809–13.PMID: 20571171.
- Houben RM, Dodd PJ. The global burden of latent tuber- culosis infection: A re-estimation using mathematical modelling. PLoS Medicine. 2016; 13(10). https://doi. org/10.1371/journal.pmed.1002152. PMid:27780211. PMCid:PMC5079585
- Suresh AJ, Nandini S, Sangeetha K, Dhivya LS, Surya PR. Design, synthesis and invitro biological evaluation of pyridine, thiadazole, benzimidazole and acetyl thiophne analogues as anti tubercular agents targeting enzyme InhA. Curr Comput-Aided. 2020. https://doi.org/10.2174/157340 9916666200724152827. PMid:32713342
- Suresh J, Baek SC, Ramakrishnan SP, Kim H, Mathew B. Discovery of potent and reversible MAO-B inhibi- tors as furanochalcones. Int J Biol Macromol. 2018; 108:660–4. https://doi.org/10.1016/j.ijbiomac.2017.11.159. PMid:29195801
- Sander T, Freyss J, von Korff M, Reich JR, Rufener C. OSIRIS, an entirely in-house developed drug discovery informatics system. J Chem Inf Model. 2009; 49(2):232–46. https://doi.org/10.1021/ci800305f. PMid:19434825
- Sabarathinam S, Vijayakumar TM. Assessment of herb- drug interactions based on the pharmacokinetic changes of probe drug, midazolam. Drug Metab Lett. 2021; 14(1):5–8. https://doi.org/10.2174/1872312814666201112122110. PMid:33183217
- Sabarathinam S, Vijayakumar TM. A short exploration of selected sensitive CYP3A4 substrates (probe drug). Drug Metab Lett. 2021; 14(1):2–4. https://doi.org/10.2174/18723 12814666200811110024. PMid:32781977
- Mittal M, Goel RK, Bhargava G, Mahajan MP. PASS-assisted exploration of antidepressant activity of 1,3,4-trisubsti- tuted-beta-lactam derivatives. Bioorganic Med Chem Lett. 2008; 18(20):5347–9. https://doi.org/10.1016/j. bmcl.2008.09.064. PMid:18835165
- Tucker EW, Dooley KE. Preclinical tools for the evalua- tion of tuberculosis treatment regimens for children. Int J Tuberc Lung Dis. 2018; 22(5):7–14. https://doi.org/10.5588/ ijtld.17.0354. PMid:29665948. PMCid: PMC7577428
- Maiolini M, Gause S, Taylor J, Steakin T, Shipp G, Lamichhane P, et al. The war against tuberculosis: A review of natural compounds and their derivatives. Molecules (Basel, Switzerland). 2020; 25(13). https://doi.org/10.3390/ molecules25133011. PMid:32630150. PMCid:PMC7412169
- Aanouz I, Belhassan A, El-Khatabi K, Lakhlifi T, El-Ldrissi M, Bouachrine M. Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. J Biomol Struct Dyn. 2021; 39(8):2971-9. https:// doi.org/10.1080/07391102.2020.1758790. PMid:32306860. PMCid:PMC7212546
- Gutierrez-Lugo MT, Bewley CA. Natural products, small molecules, and genetics in tuberculosis drug development. J Med Chem. 2008; 51(9):2606–12. https://doi.org/10.1021/ jm070719i. PMid:18393405. PMCid:PMC6260804
- Borad MA, Jethava DJ, Bhoi MN, Patel CN, Pandya HA, Patel HD. Novel isoniazid-spirooxindole derivatives: design, synthesis, biological evaluation, in silico ADMET predic- tion and computational studies. J Mol Struct. 2020; 1222. https://doi.org/10.1016/j.molstruc.2020.128881
- Guan L, Yang H, Cai Y, Sun L, Di P, Li W, et al. ADMET- score - a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm. 2018; 10(1):148– 57. https://doi.org/10.1039/C8MD00472B. PMid:30774861. PMCid:PMC6350845
- A Review on Phytoconstituents and Metal Complexes for the Treatment of Tuberculosis
Authors
1 Dr. APJ Abdul Kalam Research Laboratory, Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur – 603203, Tamil Nadu, IN
Source
Journal of Natural Remedies, Vol 23, No 1 (2023), Pagination: 1-12Abstract
Tuberculosis (TB) is an infectious lung disease. Tiny droplets discharged into the air during cough and sneezes by an individual can transmit the bacteria that cause tuberculosis from one person to another. More than one million people die each year as a result of the communicable disease tuberculosis. Anti-TB allopathic drugs have been administered to treat the disease’s symptoms; however, they can produce negative side effects such as hepatitis, hypersensitivity reactions, nausea, vomiting, etc. As a result of the toxicity and side effects of allopathic medicines, the use of herbal medicine is growing in popularity. Since ancient times, medicinal plants have been used to treat illnesses. Alkaloids, coumarins, flavonoids, polyphenols, terpenoids, quinines, and other secondary metabolites that have antibacterial activity are produced by plants and may be helpful in the treatment of tuberculosis. This review aims to explore the possible uses of medicinal herbs and metal complexes with antitubercular capabilities.Keywords
Iron Complex, Metal Complex, Terpenes, Tuberculosis.References
- Sudre P, Ten Dam G, Kochi A. Tuberculosis: A global overview of the situation today. Bulletin of the World Health Organization. 1992; 70(2):149.
- Joseph J, Nagashri K, Janaki GB. Novel metal based antituberculosis agent: Synthesis, characterization, catalytic and pharmacological activities of copper complexes. European Journal of Medicinal Chemistry. 2012; 49:151-63. https:// doi.org/10.1016/j.ejmech.2012.01.006
- Rafique S, Idrees M, Nasim A, Akbar H, Athar A. Transition metal complexes as potential therapeutic agents. Biotechnology and Molecular Biology Reviews. 2010; 5(2):38-45.
- Rai M, Ingle AP, Birla S, Yadav A, Santos CA. Strategic role of selected noble metal nanoparticles in medicine. Critical Reviews in Microbiology. 2016; 42(5):696-719.
- Keri RS, Sasidhar BS, Nagaraja BM, Santos MA. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents. European Journal of Medicinal Chemistry. 2015; 100:257-69. https://doi. org/10.1016/j.ejmech.2015.06.017
- Dueke-Eze CU, Fasina TM, Oluwalana AE, Familoni OB, Mphalele JM, Onubuogu C. Synthesis and biological evaluation of copper and cobalt complexes of (5-substituted-salicylidene) isonicotinichydrazide derivatives as antitubercular agents. Scientific African. 2020; 9:e00522. https://doi.org/10.1016/j.sciaf.2020.e00522
- Winder FG, Denneny JM. Metal-catalysed auto-oxidation of isoniazid. Biochemical Journal. 1959; 73(3):500. https:// doi.org/10.1042/bj0730500
- Chinsembu KC. Tuberculosis and nature’s pharmacy of putative anti-tuberculosis agents. Acta Tropica. 2016; 153:46-56. https://doi.org/10.1016/j.actatropica.2015.10.004
- Gutierrez-Merino C, Lopez-Sanchez C, Lagoa R, K Samhan-Arias A, Bueno C, Garcia-Martinez V. Neuroprotective actions of flavonoids. Current Medicinal Chemistry. 2011; 18(8):1195-212. https://doi. org/10.2174/092986711795029735
- Leitao SG, Castro O, Fonseca EN, Juliao LS, Tavares ES, Leo RR, Vieira RC, Oliveira DR, Leitao GG, Martino V, Sulsen V. Screening of Central and South American plant extracts for antimycobacterial activity by the Alamar Blue test. Revista Brasileira de Farmacognosia. 2006; 16:6-11. https:// doi.org/10.1590/S0102-695X2006000100003
- Carpenter CD, O’Neill T, Picot N, Johnson JA, Robichaud GA, Webster D, Gray CA. Anti-mycobacterial natural products from the Canadian medicinal plant Juniperus communis. Journal of Ethnopharmacology. 2012; 143(2):695-700. https://doi.org/10.1016/j.jep.2012.07.035
- Chinsembu KC. Tuberculosis and nature’s pharmacy of putative anti-tuberculosis agents. Acta Tropica. 2016; 153:46-56. https://doi.org/10.1016/j.actatropica.2015.10.004
- Sieniawska E, Sawicki R, Swatko-Ossor M, Napiorkowska A, Przekora A, Ginalska G, Augustynowicz-Kopec E. The effect of combining natural terpenes and antituberculous agents against reference and clinical Mycobacterium tuberculosis strains. Molecules. 2018; 23(1):176. https://doi. org/10.3390/molecules23010176
- Sieniawska E, Swatko-Ossor M, Sawicki R, SkalickaWoźniak K, Ginalska G. Natural terpenes influence the activity of antibiotics against isolated Mycobacterium tuberculosis. Medical Principles and Practice. 2017; 26(2):108-12. https://doi.org/10.1159/000454680
- Moussa AY, Sobhy HA, Eldahshan OA, Singab AN. Caspicaiene: A new kaurene diterpene with anti-tubercular activity from an Aspergillus endophytic isolate in Gleditsia caspia desf. Natural Product Research. 2021; 35(24):5653- 64. https://doi.org/10.1080/14786419.2020.1824222
- Umumararungu T, Mukazayire MJ, Mpenda M, Mukanyangezi MF, Nkuranga JB, Mukiza J, Olawode EO. A review of recent advances in anti-tubercular drug development. Indian Journal of Tuberculosis. 2020; 67(4):539-59. https://doi.org/10.1016/j.ijtb.2020.07.017
- Bollikolla HB, Tyagi R, Gokada MR, Anandam R, Kasthuri JK, Alam MM, Mannam KM. Flavones as Important Scaffolds for Anticancer, Antioxidant and Anti-Tubercular Activities: An Overview of Reports 2015–2020. Moscow University Chemistry Bulletin. 2022; 77(5):269-85. https:// doi.org/10.3103/S0027131422050042
- Banci L, Sigel A, Sigel H, Sigel RK. Metallomics and the cell. Metal Ions in Life Sciences.
- Andreini C, Banci L, Bertini I, Rosato A. Zinc through the three domains of life. Journal of Proteome Research. 2006; 5(11):3173-8. https://doi.org/10.1021/pr0603699
- Kusalik A, Bickis M, Lewis C, Li Y, Lucchese G, Marincola FM, Kanduc D. Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes. Peptides. 2007; 28(6):1260-7. https://doi.org/10.1016/j.peptides.2007.04.001
- King JV, Liang WG, Scherpelz KP, Schilling AB, Meredith SC, Tang WJ. Molecular basis of substrate recognition and degradation by human presequence protease. Structure. 2014; 22(7):996-1007. https://doi.org/10.1016/j. str.2014.05.003
- Rawlings ND, Barrett AJ. Evolutionary families of metallopeptidases. In Methods in enzymology. Academic Press. 1995; l(248):183-228. https://doi.org/10.1016/0076- 6879(95)48015-3
- Minde DP, Maurice MM, Rüdiger SG. Determining biophysical protein stability in lysates by a fast proteolysis assay, FASTpp.
- Thomas NV, Kim SK. Metalloproteinase inhibitors: status and scope from marine organisms. Biochemistry Research International. 2010; 2010. https://doi. org/10.1155/2010/845975
- Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiological Reviews. 2005; 85(1):1-31. https:// doi.org/10.1152/physrev.00048.2003
- Shah PK. Inflammation, metalloproteinases, and increased proteolysis: An emerging pathophysiological paradigm in aortic aneurysm. Circulation. 1997; 96(7):2115-7. https:// doi.org/10.1161/01.CIR.96.7.2115
- Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circulation Research. 2003; 92(8):827-39. https://doi.org/10.1161/01.RES.0000070112.80711.3D
- Hideaki N. Matrix metalloproteinases. Journal of Biological Chemistry. 1999; 274(31):21491-4. https://doi.org/10.1074/ jbc.274.31.21491
- Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T, Matsusaka H, Kubota T, Imanaka-Yoshida K, Itoh T, Takeshita A. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. American Journal of Physiology-Heart and Circulatory Physiology. 2003; 285(3):H1229-35. https://doi. org/10.1152/ajpheart.00207.2003
- Matsusaka H, Ide T, Matsushima S, Ikeuchi M, Kubota T, Sunagawa K, Kinugawa S, Tsutsui H. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload. Hypertension. 2006; 47(4):711-7. https://doi.org/10.1161/01. HYP.0000208840.30778.00
- Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nature medicine. 1999; 5(10):1135-42. https://doi. org/10.1038/13459
- Alessio E, Editor. Bioinorganic medicinal chemistry. John Wiley and Sons. 2011. https://doi. org/10.1002/9783527633104
- Barry NP, Sadler PJ. Exploration of the medical periodic table: Towards new targets. Chemical Communications. 2013; 49(45):5106-31. https://doi.org/10.1039/c3cc41143e
- Bruijnincx PC, Sadler PJ. New trends for metal complexes with anticancer activity. Current Opinion in Chemical Biology. 2008; 12(2):197-206. https://doi.org/10.1016/j. cbpa.2007.11.013
- Gasser G. Metal complexes and medicine: A successful combination. Chimia. 2015; 69(7-8):442. https://doi. org/10.2533/chimia.2015.442
- Johnstone TC, Suntharalingam K, Lippard SJ. The next generation of platinum drugs: targeted Pt (II) agents, nanoparticle delivery, and Pt (IV) prodrugs. Chemical Reviews. 2016; 116(5):3436-86. https://doi.org/10.1021/acs. chemrev.5b00597
- Shingnapurkar D, Dandawate P, Anson CE, Powell AK, Afrasiabi Z, Sinn E, Pandit S, Swamy KV, Franzblau S, Padhye S. Synthesis and characterization of pyruvate–isoniazid analogs and their copper complexes as potential ICL inhibitors. Bioorganic and Medicinal Chemistry Letters. 2012; 22(9):3172-6. https://doi.org/10.1016/j.bmcl.2012.03.047
- Silva PB, Souza PC, Calixto GM, Lopes ED, Frem RC, Netto AV, Mauro AE, Pavan FR, Chorilli M. In vitro activity of copper (II) complexes, loaded or unloaded into a nanostructured lipid system, against Mycobacterium tuberculosis. International Journal of Molecular Sciences. 2016; 17(5):745. https://doi.org/10.3390/ijms17050745
- Firmino GS, de Souza MV, Pessoa C, Lourenco M, Resende JA, Lessa JA. Synthesis and evaluation of copper (II) complexes with isoniazid-derived hydrazones as anticancer and antitubercular agents. BioMetals. 2016; 29(6):953-63. https://doi.org/10.1007/s10534-016-9968-7.
- Sato MR, Oshiro Junior JA, Machado RT, de Souza PC, Campos DL, Pavan FR, da Silva PB, Chorilli M. Nanostructured lipid carriers for incorporation of copper (II) complexes to be used against Mycobacterium tuberculosis. Drug Design, Development and Therapy. 2017; 2017(11):909-21. https://doi.org/10.2147/DDDT.S127048
- Barbosa AR, Caleffi-Ferracioli KR, Leite CQ, GarciaRamos JC, Toledano-Magana Y, Ruiz-Azuara L, Siqueira VL, Pavan FR, Cardoso RF. Potential of Casiopeínas® copper complexes and antituberculosis drug combination against Mycobacterium tuberculosis. Chemotherapy. 2016; 61(5):249-55. https://doi.org/10.1159/000443496
- Belwal S, Kariveda S, Ramagiri S. Study on Synthesis, Characterization and Antituberculosis Activity of Biologically Nanostructured Zinc and Titanium Metal Compounds. New Innovations in Chemistry and Biochemistry. 2021; 5:60-70. https://doi.org/10.9734/bpi/ nicb/v5/14502D
- Hadda TB, Akkurt M, Baba MF, Daoudi M, Bennani B, Kerbal A, Chohan ZH. Anti-tubercular activity of ruthenium (II) complexes with polypyridines. Journal of Enzyme Inhibition and Medicinal Chemistry. 2009; 24(2):457-63. https://doi.org/10.1080/14756360802188628
- Singh R, Nawale L, Arkile M, Wadhwani S, Shedbalkar U, Chopade S, Sarkar D, Chopade BA. Phytogenic silver, gold, and bimetallic nanoparticles as novel antitubercular agents. International Journal of Nanomedicine. 2016; 11:1889. https://doi.org/10.2147/IJN.S102488
- Tarallo MB, Urquiola C, Monge A, Costa BP, Ribeiro RR, Costa-Filho AJ, Mercader RC, Pavan FR, Leite CQ, Torre MH, Gambino D. Design of novel iron compounds as potential therapeutic agents against tuberculosis. Journal of Inorganic Biochemistry. 2010; 104(11):1164-70. https://doi. org/10.1016/j.jinorgbio.2010.07.005
- Savic-Gajic IM, Savić IM. Drug design strategies with metal-hydroxyquinoline complexes. Expert Opinion on Drug Discovery. 2020; 15(3):383-90. https://doi.org/10.108 0/17460441.2020.1702964
- Deuterium - A Natural Isotope to Combat Microbial Resistance
Authors
1 Dr APJ Abdul Kalam Research Laboratory, Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur – 603203, Tamil Nadu, IN
2 Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER) Hajipur District: Vaishali, Hajipur - 844102, Bihar, IN
3 Faculty of Pharmacy, Karpagam Academy of Higher Education, Pollachi Main Road, Eachanari Post, Coimbatore - 641021, Tamil Nadu, IN
4 Department of Pharmacognosy and Phytochemistry, Parul Institute of Pharmacy and Research, Parul University, Vadodara, Gujarat – 391760, IN
Source
Journal of Natural Remedies, Vol 23, No 2 (2023), Pagination: 295-305Abstract
Deuterated medicinal chemistry is an attempt to introduce deuterium into existing drug molecules through the replacement of hydrogen atoms (-H) with deuterium (-D). The process of deuteration is to reduce the rates of breaking the carbonhydrogen bond. If the carbon-hydrogen bond breaking is the rate-determining step in the biotransformation of the drug, the deuterated drug may show improved pharmacokinetic characteristics, such as a longer half-life, hence lowering the need for frequent dosing. In this review, we discuss the improvement in the drug’s pharmacokinetic profile with deuterium. Further, this Deuterium exchange chemistry can reduce toxicity and be safe for human use. Also, the drugs experimented with using deuterium are discussed as how deuterated chemistry can help fight antimicrobial resistance. Beyond all, still, the design and development of a successful deuterated drug with acceptable efficacy is hence a challenge. The translation of hypotheses from laboratory experiments to clinical application and further to real-time practice is unpredictable. Also, long-term drug stability and toxicity studies for individual drugs are to be studied which may vary from patient to patient.Keywords
Antimicrobial Resistance, Deuterium, Metronidazole, Pharmacokinetic PropertyReferences
- Urey HC, Brickwedde FG, Murphy GM. A hydrogen isotope of mass 2. Physical Review. 1932; 39(1):164. https://doi.org/10.1103/PhysRev.39.164
- Harbeson SL, Tung RD. Deuterium in drug discovery and development. In Annual Reports in Medicinal Chemistry. Academic Press; 2011. p. 403-417. https://doi.org/10.1016/ B978-0-12-386009-5.00003-5
- Pirali T, Serafini M, Cargnin S, Genazzani AA. Applications of deuterium in medicinal chemistry. Journal of Medicinal Chemistry. 2019; 62(11):5276-97. https://doi.org/10.1021/acs.jmedchem.8b01808 PMid:30640460
- Bartell LS, Roth EA, Hollowell CD, Kuchitsu K, Young Jr JE. Electron‐diffraction study of the structures of C2H4 and C2D4. The Journal of Chemical Physics. 1965; 42(8):2683- 6. https://doi.org/10.1063/1.1703223
- Nelson SD, Trager WF. The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity. Drug Metabolism and Disposition. 2003; 31(12):1481-97. https://doi.org/10.1124/dmd.31.12.1481 PMid:14625345
- Gant TG. Using deuterium in drug discovery: Leaving the label in the drug. Journal of Medicinal Chemistry. 2014; 57(9):3595-611. https://doi.org/10.1021/jm4007998 PMid:24294889
- Meanwell NA. Synopsis of some recent tactical application of bioisosteres in drug design. Journal of Medicinal Chemistry. 2011; 54(8):2529-91. https://doi.org/10.1021/jm1013693 PMid:21413808
- Croom E. Metabolism of xenobiotics of human environments. Progress in molecular biology and translational science. 2012; 112:31-88. https://doi.org/10.1016/B978-0-12-415813-9.00003-9 PMid:22974737
- Timmins GS. Deuterated drugs; updates and obviousness analysis. Expert Opinion on Therapeutic Patents. 2017; 27(12):1353-61. https://doi.org/10.1080/13543776.2017.1378350 PMid:28885861
- Schmidt C. First deuterated drug approved. Nature Biotechnology. 2017; 35(6):493-5. https://doi.org/10.1038/ nbt0617-493 PMid:28591114
- Anderson KE, Stamler D, Davis MD, Factor SA, Hauser RA, Isojärvi J, Jarskog LF, Jimenez-Shahed J, Kumar R, McEvoy JP, Ochudlo S. Deutetrabenazine for treatment of involuntary movements in patients with Tardive Dyskinesia (AIM-TD): A double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet Psychiatry. 2017; 4(8):595-604. https://doi.org/10.1016/S2215-0366(17)30236-5 PMid:28668671
- Citrome L. Breakthrough drugs for the interface between psychiatry and neurology. International Journal of Clinical Practice. 2016; 70(4):298-9. https://doi.org/10.1111/ijcp.12805 PMid:27028671
- Coppen EM, Roos RA. Current pharmacological approaches to reduce chorea in Huntington’s disease. Drugs. 2017; 77:29-46. https://doi.org/10.1007/s40265-016-0670-4 PMid:27988871 PMCid:PMC5216093
- Rosenberg R, Roth T, Scharf MB, Lankford DA, Farber R. Efficacy and tolerability of indiplon in transient insomnia. Journal of Clinical Sleep Medicine. 2007; 3(4):374-9. https:// doi.org/10.5664/jcsm.26859 PMid:17694726 PMCid: PMC1978303
- Harbeson SL, Tung RD. Deuterium in drug discovery and development. Annual Reports in Medicinal Chemistry. Academic Press; 2011. p. 403-417. https://doi.org/10.1016/ B978-0-12-386009-5.00003-5
- Schneider, Frank, Hillgenberg M, Koytchev R, Alken R-G. Enhanced plasma concentration by selective deuteration of rofecoxib in rats. Arzneimittelforschung. 2006; 56(4):295-300. https://doi.org/10.1055/s-0031-1296724 PMid:16724516
- Morgan AJ, Pandya BA, Masse CE, Harbeson SL. Old drugs yield new discoveries: Examples from the prodrug, chiral switch, and site‐selective deuteration strategies. Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs; 2012. p. 291. https:// doi.org/10.1002/9781118274408.ch10 PMid:23133329 PMCid:PMC3484954
- Janni M, Peruncheralathan S. Catalytic selective deuteration of halo (hetero) arenes. Organic & Biomolecular Chemistry. 2016; 14(11):3091-7. https://doi.org/10.1039/C6OB00193A PMid:26899945
- DeWitt SH, Maryanoff BE. Deuterated drug molecules: Focus on FDA-approved deutetrabenazine: Published as part of the biochemistry series “biochemistry to bedside”. Biochemistry. 2018; 57(5):472-3. https://doi.org/10.1021/acs.biochem.7b00765 PMid:29160059
- Mori T, Ito T, Liu S, Ando H, Sakamoto S, Yamaguchi Y, Tokunaga E, Shibata N, Handa H, Hakoshima T. Structural basis of thalidomide enantiomer binding to cereblon. Scientific Reports. 2018; 8(1):1-4. https://doi. org/10.1038/s41598-018-19202-7 PMid:29358579 PMCid: PMC5778007
- acques V, Bolze S, Hallakou‐Bozec S, Czarnik AW, Divakaruni AS, Fouqueray P, Murphy AN, Van der Ploeg LH, DeWitt S. Deuterium‐stabilized (R)‐pioglitazone (PXL065) is responsible for pioglitazone efficacy in NASH yet exhibits little to no PPARγ activity. Hepatology Communications. 2021; 5(8):1412-25. https://doi.org/10.1002/hep4.1723 PMid:34430785 PMCid:PMC8369945
- Maltais F, Jung YC, Chen M, Tanoury J, Perni RB, Mani N, Laitinen L, Huang H, Liao S, Gao H, Tsao H. In vitro and in vivo isotope effects with hepatitis C protease inhibitors: Enhanced plasma exposure of deuterated telaprevir versus telaprevir in rats. Journal of Medicinal Chemistry. 2009; 52(24):7993-8001. https://doi.org/10.1021/jm901023f PMid:19894743
- Hill S, Lamberson CR, Xu L, To R, Tsui HS, Shmanai VV, Bekish AV, Awad AM, Marbois BN, Cantor CR, Porter NA. Small amounts of isotope-reinforced polyunsaturated fatty acids suppress lipid autoxidation. Free Radical Biology and Medicine. 2012; 53(4):893-906. https://doi. org/10.1016/j.freeradbiomed.2012.06.004 PMid:22705367 PMCid:PMC3437768
- Lamberson CR, Xu L, Muchalski H, Montenegro-Burke JR, Shmanai VV, Bekish AV, McLean JA, Clarke CF, Shchepinov MS, Porter NA. Unusual kinetic isotope effects of deuterium reinforced polyunsaturated fatty acids in tocopherol-mediated free radical chain oxidations. Journal of the American Chemical Society. 2014; 136(3):838-41. https://doi.org/10.1021/ja410569g PMid:24380377 PMCid: PMC4578730
- Klein PD, Klein ER. Stable isotopes: origins and safety. The Journal of Clinical Pharmacology. 1986; 26(6):378-82. https://doi.org/10.1002/j.1552-4604.1986.tb03544.x PMid: 3734125
- Baum D, Dobbing J, Coward WA. Deuterium method for measuring milk intake in babies. Lancet. 1979. https://doi. org/10.1016/S0140-6736(79)90327-1 PMid:88642
- Butte NF, Wong WW, Klein PD, Garza C. Measurement of milk intake: Tracer-to-infant deuterium dilution method. British Journal of Nutrition. 1991; 65(1):3-14. https://doi.org/10.1079/BJN19910060 PMid:1997129
- Pons G, Rey E. Stable isotopes labeling of drugs in pediatric clinical pharmacology. Pediatrics. 1999; 104(Supplement_3):633-9. https://doi.org/10.1542/peds. 104. S3.633 PMid:10469806
- Rodewald LE, Maiman LA, Foye HR, Borch RF, Forbes GB. Deuterium oxide as a tracer for measurement of compliance in pediatric clinical drug trials. The Journal of Pediatrics. 1989; 114(5):885-91. https://doi.org/10.1016/S0022-3476(89)80159-3 PMid:2541239
- White RD, Gandolfi AJ, Bowden GT, Sipes IG. Deuterium isotope effect on the metabolism and toxicity of 1, 2-dibromoethane. Toxicology and Applied Pharmacology. 1983; 69(2):170-8. https://doi.org/10.1016/0041-008X(83) 90297-1 PMid:6346586
- Branchflower RV, Nunn DS, Highet RJ, Smith JH, Hook JB, Pohl LR. Nephrotoxicity of chloroform: Metabolism to phosgene by the mouse kidney. Toxicology and Applied Pharmacology. 1984; 72(1):159-68. https://doi. org/10.1016/0041-008X(84)90260-6 PMid:6143425
- Kushner DJ, Baker A, Dunstall TG. Pharmacological uses and perspectives of heavy water and deuterated compounds. Canadian Journal of Physiology and Pharmacology. 1999; 77(2):79-88. https://doi.org/10.1139/y99-005 PMid: 10535697
- Carlstedt BC, Crespi HL, Blake MI, Katz JJ. Biosynthesis of deuterated benzylpenicillins III: Relative antibiotic potency of highly deuterated benzylpenicillin. Journal of Pharmaceutical Sciences. 1973; 62(5):856-7. https://doi. org/10.1002/jps.2600620546 PMid:4705709
- Fischer JJ, Jardetzky O. Nuclear magnetic relaxation study of intermolecular complexes. The mechanism of penicillin binding to serum albumin1a. Journal of the American Chemical Society. 1965; 87(14):3237-44. https://doi. org/10.1021/ja01092a040 PMid:14329431
- Katz JJ, Crespi HL. Isotope effects in chemical reactions. New York, NY, USA: Van Nostrand Reinhold; 1971.
- Alffenaar JW, Bolhuis M, Van Hateren K, Sturkenboom M, Akkerman O, de Lange W, Greijdanus B, van der Werf T, Touw D. Determination of bedaquiline in human serum using liquid chromatography-tandem mass spectrometry. Antimicrobial Agents and Chemotherapy. 2015; 59(9):5675-80. https://doi.org/10.1128/AAC.00276-15 PMid:26149993 PMCid:PMC4538542
- Cox E, Laessig K. FDA approval of bedaquiline- the benefit-risk balance for drug-resistant tuberculosis. New England Journal of Medicine. 2014; 371(8):689-91. https://doi.org/10.1056/NEJMp1314385 PMid:25140952
- Bhadra PK, Hassanzadeh A, Arsic B, Allison DG, Morris GA, Barber J. Enhancement of the properties of a drug by mono-deuteriation: Reduction of acid-catalysed formation of a gut-motilide enol ether from 8-deuterio-erythromycin B. Organic and Biomolecular Chemistry. 2016; 14(26):6289- 96. https://doi.org/10.1039/C6OB00785F PMid:27273525
- Norcott P, Rayner PJ, Green GG, Duckett SB. Achieving high 1H nuclear hyperpolarization levels with long lifetimes in a range of tuberculosis drug scaffolds. Chemistry- A European Journal. 2017; 23(67):16990-7. https://doi. org/10.1002/chem.201703278 PMid:28990279
- Liu R, Krchnak V, Brown SN, Miller MJ. Deuteration of BTZ043 extends the lifetime of meisenheimer intermediates to the antituberculosis nitroso oxidation state. ACS Medicinal Chemistry Letters. 2019; 10(10):1462-6. https:// doi.org/10.1021/acsmedchemlett.9b00308 PMid:31620234 PMCid:PMC6792150
- Harbeson SL, Tung RD. Deuterium in drug discovery and development. Annual Reports in Medicinal Chemistry. Academic Press; 2011. p. 403-417. https://doi.org/10.1016/ B978-0-12-386009-5.00003-5
- Reider PJ, Conn RS, Davis P, Grenda VJ, Zambito AJ, Grabowski EJ. Synthesis of (R)-serine-2-d and its conversion to the broad-spectrum antibiotic fludalanine. The Journal of Organic Chemistry. 1987; 52(15):3326-34. https://doi.org/10.1021/jo00391a029
- Morgan AJ, Pandya BA, Masse CE, Harbeson SL. Old drugs yield new discoveries: Examples from the prodrug, chiral switch, and site‐selective deuteration strategies. Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs; 2012. p. 291. https:// doi.org/10.1002/9781118274408.ch10 PMid:23133329 PMCid:PMC3484954
- Anjana GV, Kathiravan MK. Antimicrobial activity of curcumin and deuterated curcumin. Journal of Natural Remedies. 2022; 22(3):424-31. https://doi.org/10.18311/ jnr/2022/29686
- Anjana GV. Synthesis and antimicrobial evaluation of deuterated analogues of metronidazole. Iraqi Journal of Pharmaceutical Sciences. 2022; 31(2):297-303. https://doi.org/10.31351/vol31iss2pp297-303